Last updated on February 2018

Assess the safety and tolerability of an investigational medication for insomnia compared with Zolpidem and Placebo in subjects with Insomnia Disorder between the ages of 18-85.


Brief description of study

 

The purpose of this research study is to assess the safety and tolerability of an investigational medication foe insomnia compared with zolpidem and placebo in subjects with insomnia disorder. This study is comprised of 2 office visits, 6 overnight stays, and one phone call over approximately 2 months. The first visit consists of a physical with our physician, blood draw, ECG, urine specimen collection and urine drug screen. 

Clinical Study Identifier: TX155602

Contact Investigators or Research Sites near you

Start Over

Tim Thurman

Neurotrials Research, Inc.
Atlanta, GA United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.